PharmTech Drug Digest 11.20

Robert J. Seely

Member of BioPharma International's advisory board and associate director of corporate validation, corporate QA

Articles by Robert J. Seely

Pharmaceutical Technology Europe

Determining whether a data point is an "outlier" - a result that does not fit, is too high or too low, is extreme or discordant - is difficult when using small data sets, such as the data from three, four or five conformance runs. In this article, the authors demonstrate that the Weisberg t-test is a powerful tool for detecting deviations in small data sets.

Latest Updated Articles